Brenda Cseremsak

Brenda Cseremsak has extensive experience in pharmacovigilance and drug safety. Brenda is currently the Manager of PV Sciences at Taiho Oncology, Inc., a position they have held since March 2020. Previously, they worked as a Pharmacovigilance Manager at Amicus Therapeutics from August 2019 to March 2020. Before that, Brenda was the Manager of PV Contracts & External Affairs at Taiho Oncology, Inc. from January 2013 to August 2019.

Brenda'searlier experience includes working as a Drug Safety Monitor in the Drug Safety Department at Bracco Diagnostics from September 2007 to January 2013. In this role, they reviewed and processed adverse event data, ensuring compliance with regulatory standards. Prior to that, they served as the Manager of Drug Safety Surveillance at Kyowa Pharmaceutical, Inc. from February 2003 to May 2007. In this position, Brenda entered and processed serious adverse event data from clinical trials and provided training to clinical staff on regulatory requirements.

Brenda also has experience at BMS, where they held various roles starting in 1985. Brenda worked as a Senior Regulatory Affairs Associate from January 2000 to February 2003 and as a Regulatory Safety Associate from January 1991 to December 1999. Brenda'sresponsibilities in these positions included supporting drug safety efforts, coordinating litigation support, and entering adverse event and product defect data into a database.

Overall, Brenda Cseremsak has a wealth of experience in pharmacovigilance, drug safety, and regulatory affairs, encompassing both managerial and operational roles throughout their career.

Brenda Cseremsak's education history begins in 1981 when they enrolled at Bucks County Community College. Brenda completed their Associate of Arts degree in Medical Secretarial Science in 1983. After that, they attended Rider University from 1987 to 1993, where they obtained a Bachelor of Science degree in Office Administration.